Showing 221 - 240 results of 474 for search '"inflammation"', query time: 0.06s Refine Results
  1. 221
  2. 222

    Meconium Peritonitis and Periorchitis: Report of a Prenatal Case by Cem Yaşar Sanhal, İnanç Mendilcioğlu, Adnan Aslan, Murat Özekinci, Mehmet Şimşek

    Published 2014-12-01
    “… Meconium peritonitis refers to rupture of the bowel prior to birth, resulting in fetal meconium escaping into peritoneum leading to inflammation (peritonitis). Meconium periorchitis is an extension of meconium peritonitis into the scrotum via a patent processus vaginalis. …”
    Get full text
    Article
  3. 223

    Association of neutrophil-to-lymphocyte ratio and monocyte-tolymphocyte ratio with all-cause mortality in patients with ischemia and non-obstructive coronary arteries by Mihai Emilian Dumitru, Delcea Caterina, Buzea Adrian Cătălin, Dan Gheorghe-Andrei

    Published 2025-01-01
    “…Ischemia with non-obstructive coronary arteries (INOCA) is a frequent coronary syndrome with important impact on morbimortality. Systemic inflammation, a key pathophysiological mechanism in its development, is reflected in diverse bio-markers, such as the neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR) and platelet-to-lymphocyte ratio (PLR). …”
    Get full text
    Article
  4. 224

    Acetylcholine in irritable bowel syndrome pathogenesis and the role of cholineblockers by Yu. O. Shulpekova

    Published 2011-02-01
    “…Experimental data allow to assume, that «subclinical inflammation» within intestinal wall at IBS, disturbances of peristaltic activity and hyperalgesia, are related to altered response of immune and smooth-muscle cells to acetylcholine stimulation.Conclusion. …”
    Get full text
    Article
  5. 225
  6. 226

    Effect of rifampicin on the kidney of albino rats by DE Peters, AO Chike

    Published 2013-07-01
    “…Histological examination of the kidney revealed an inflammation of the glomeruli for 1.10mg/120gBW treated group in 60days. …”
    Get full text
    Article
  7. 227

    Biological therapy for inflammatory bowel disease: cyclical rather than lifelong treatment? by Christian Philipp Selinger, Konstantina Rosiou, Marco V Lenti

    Published 2024-06-01
    “…Treatment guidelines highlight the need for effective control of inflammation and early escalation to advanced therapies to avoid long-term complications. …”
    Get full text
    Article
  8. 228

    The crucial role of 5hmC in neuroprotection and repair after cerebrovascular injury by Yanina Tsenkina

    Published 2024-07-01
    “…The discussion delves into the dynamic interaction between hydroxymethylation and important pathways in neuroprotection, such as the modulation of excitotoxicity and cellular metabolism, resolution of inflammation, and mitigation of oxidative stress. Additionally, it explores emerging evidence suggesting that 5hmC contributes to neurorepair by promoting neurogenesis, axonal regeneration, angiogenesis, and synaptic plasticity. …”
    Get full text
    Article
  9. 229

    Research Progress on Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Knee Osteoarthritis by GONG Jin, ZHANG Jinjin, CHEN Lili, WANG Hui, XING Yanchao

    Published 2025-01-01
    “…Knee osteoarthritis (KOA) is a prevalent degenerative joint disease characterized by synovial inflammation, cartilage loss. Often manifesting as joint pain and limited mobility, it severely affects the quality of life of patients. …”
    Get full text
    Article
  10. 230

    Primary biliary cirrhosis: clinical and laboratory criteria of diagnostics and up-to-date treatment by L. Yu. Il’chenko, V. I. Reshetn’yak

    Published 2011-09-01
    “…PBC is organ-specific autoimmune liver disease affecting predominantly women that is characterized by chronic progressing destruction of intrahepatic bile ducts with portal inflammation, resulting in development of liver cirrhosis (LC). …”
    Get full text
    Article
  11. 231

    Functional status, lymphocyte-to-monocyte ratio, and platelet-to-lymphocyte ratio as prognostic factors of one-year survival rate in elderly patients with advanced-stage non-small... by Ratna Nurhayati, Aulia Rizka, Cleopas Martin Rumende, Noorwati Sutandyo, Arif Hanafi, Edy Rizal Wahyudi, Hamzah Shatri, Anna Mira Lubis, Em Yunir, Muhammad Firdaus, Yuniar Harris Prayitno, Nadira Nibras Taqiyya

    Published 2024-01-01
    “…Aging and chronic inflammation are related to its pathogenesis. Functional status, lymphocyte-to-monocyte ratio and platelet-to-lymphocyte ratio describe a chronic inflammation and correlate to the survival of older adults with advanced-stage (IIIB-IV) NSCLC. …”
    Get full text
    Article
  12. 232

    Effects of biologic therapy on novel indices of lung inhomogeneity in patients with severe type-2 high asthma by Nayia Petousi, Nick P Talbot, Ian Pavord, Peter A Robbins, Nicholas M J Smith, Graham Richmond, Asma Alamoudi, Lorenzo Petralia, Haopeng Xu, Dominic Sandhu, Grant AD Ritchie

    Published 2025-02-01
    “…Responders, unlike Non-Responders, experienced significant improvements in symptoms and FEV1 % predicted (Δ pre-BD FEV115±15% pred, p<0.001) and included a higher proportion of patients in clinical remission at 1 year.Conclusion σlnCl is strongly associated with systemic eosinophilic inflammation in severe type-2 high asthma. An early σlnCl response following anti-IL5 biologics identifies patients more likely to experience improvements in symptoms and lung function when systemic eosinophils are depleted. σlnCl may provide a sensitive route for tracking inflammation involving the small airways.…”
    Get full text
    Article
  13. 233

    Diagnostics and treatment of Clostridium difficile-associated disease: Guidelines of the Russian gastroenterological association by V. T. Ivashkin, N. D. Yushchuk, I. V. Mayev, Tatyana L Lapina, Ye. A. Poluektova, O. S. Shifrin, A. S. Tertychny, A. S. Trukhmanov, A. A. Sheptulin, Ye. K. Baranskaya, O. S. Lyashenko, K. V. Ivashkin

    Published 2018-08-01
    “…Clostridium difficile-associated disease develops at disorders of intestinal microbiome with excessive colonization of C. difficile which toxins cause colonic inflammation and damage. C. difficile toxins A and B are major virulence factors causing damage of intestinal wall and inflammation due to damage of intestinal epithelial barrier, induction of proinflammatory cytokines, apoptosis and a necrosis of epithelial cells. …”
    Get full text
    Article
  14. 234

    Family case of cardiac achalasia by Yu. V. Yevsyutina, A. S. Trukhmanov, V. T. Ivashkin

    Published 2014-10-01
    “…Cardiac achalasia is idiopathic disease, caused by inflammation and degeneration of myenteric plexus resulting in loss of postganglionic inhibitory neurons, essential for relaxation of the lower esophageal sphincter and peristaltic contractions of the esophagus. …”
    Get full text
    Article
  15. 235

    Microbiome in development of esophageal diseases by Yu. V. Yevsyutina, V. T. Ivashkin

    Published 2016-08-01
    “…Toll-like receptors, cytokines, nuclear factor κB, cyclooxygenase-2 can be potential mediators of inflammation and carcinogenesis which expression can be modified by microbiome spectrum. …”
    Get full text
    Article
  16. 236

    Irritable Bowel and Bacterial Overgrowth Syndromes: a Bacterial Link Hypothesis of Functional Disease by K. V. Ivashkin, V. R. Grechishnikova, M. S. Reshetova, V. T. Ivashkin

    Published 2021-04-01
    “…SIBO may represent a "peripheral" mechanism of IBS, aside to nonspecific inflammation, increased epithelial permeability and local immune system activation. …”
    Get full text
    Article
  17. 237

    Non-invasive of liver fibrosis diagnostics: the role of serum markers by A. F. Sheptulina, Ye. N. Shirokova, V. T. Ivashkin

    Published 2015-05-01
    “…Investigations in the field of fibrogenesis processes made possible quantitative estimation of liver fibrosis by non-invasive tests based both on assessment of peripheral blood levels of substances, directly involved in various stages of extracellular matrix synthesis and disintegration, and on the routine laboratory tests reflecting activity of inflammation, degree of disorder of synthetic liver function and fibrosis progression.Conclusion. …”
    Get full text
    Article
  18. 238

    Sex-specific influences of APOEε4 genotype on hippocampal neurogenesis and progenitor cells in middle-aged rats by Bonnie H. Lee, Melike Cevizci, Stephanie E. Lieblich, Liisa A. M. Galea

    Published 2025-02-01
    “…Compared to healthy controls, male rats with hAPOEε4 genotype showed reduced neural stem cell-like cells and new adult-born brain cells and increased microglia (marker of inflammation in the brain) at middle age. In contrast, female rats with hAPOEε4 genotype showed increased new adult-born neurons, but no changes in the other cell types, suggesting a possible compensatory response to the effects of hAPOEε4 at this time point. …”
    Get full text
    Article
  19. 239

    Rebamipide during chronic gastritis: <i>H. pylori</i> eradication therapy and restoration of gastric mucosa barrier function by Т. L. Lapina, V. T. Ivashkin

    Published 2024-01-01
    “…Experimental and clinical studies have demonstrated that rebamipide increases concentration of prostaglandins (prostaglandin E2 and prostacyclin) and production of mucin, manages inflammation and oxidative stress, controls apoptosis and autophagy. …”
    Get full text
    Article
  20. 240

    Compliant immune response of silk-based biomaterials broadens application in wound treatment by Zhiqiang Tian, Hong Chen, Ping Zhao

    Published 2025-02-01
    “…In this review, we elaborate on the inflammation and immune responses caused by the implantation of sericin and SF and also explore their anti-inflammatory properties and immune regulatory functions. …”
    Get full text
    Article